Ichiro Nakachi

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 636 citations · Full text

Medicine, Oncology, Pharmacology +12

Comparison of Rapid Antigen Tests for COVID-19

Seiya Yamayoshi, Yuko Sakai‐Tagawa, Michiko Koga et al. · Viruses · 2020 · 226 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +16

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito et al. · EClinicalMedicine · 2021 · 169 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

Hideo Watanabe, Kenzo Soejima, Hiroyuki Yasuda et al. · Cancer Cell International · 2008 · 153 citations · Full text

Life Sciences, Genetics, Oncology +15

Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease

Moumita Ghosh, York E. Miller, Ichiro Nakachi et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 122 citations

Medicine, Cell Biology, Physiology +17